-
Bezisterim may help with some Long COVID symptoms, drug’s developer reports in early trial results
While the phase 2 clinical trial results, shared by BioVie in a webinar on Tuesday, have yet to be peer-reviewed, investigators say they can inform a confirmatory phase 3 trial. Read more…
Recent articles
Get the latest Long COVID news and commentary
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Check out our weekly podcast, Still Here
Spotify
Apple Podcasts
PocketCasts
iHeartRadio
RSSTrending
Policy & Advocacy
Science
-
Research updates, April 15
-
“It’s like torture”: The tilt table test could be risky for many people with Long COVID
-
Research updates, April 8
-
Lisa McCorkell reflects on five years of Long COVID research, and leaving PLRC
-
What we know about the U.S. bird flu outbreak and its chronic disease risk
-
Research updates, April 1
Covid-19
Health
-
New CDC data identify more than 5,000 Long Covid deaths, but tally is likely a significant undercount
-
HHS gave million-dollar grants to nine Long Covid clinics; here’s how they plan to use the funding
-
HIV may increase the risk of Long Covid. Why aren’t major advocacy groups addressing it?
-
Project N95 ending mask store, free distributions by the end of 2023
-
What’s happening this week, November 21
-
Breast cancer exposed the lack of care I receive for Long COVID
-
“This exhaustion is cellular”: Excerpts from the new book ‘What Is Myalgic Encephalomyelitis Like?’
-
There’s a long history of person-first language in advocacy. Here’s why we should use it for Long COVID.
-
The (sick) kids aren’t alright: Observations from a teacher with Long COVID